22 Feb RxAdvocate August, 2022 — Newsletter
Dobbs v. Jackson FDA Vitiligo Therapy Consolidated Appropriations Act ...
Newsletter
22 Feb RxAdvocate July, 2022 — Newsletter
UV Safety Month Omnipod Coverage Sildenafil Recognized as Candidate for Alzheimer's RxConnection Team Involvement...
27 Jun RxAdvocate June, 2022 — Newsletter
FDA Approves Alopecia Drug Cancer Study Results in 100% Patient Remission COVID-19 & Cardiovascular Health COVID-19 Vaccinations Authorized - Children 4 & Under RxConnection Organization Announcements...
27 Jun RxAdvocate May, 2022 — Newsletter
CVD Prevention With Aspirin Kids Aged 4 & Under - COVID-19 Vaccines FDA Withdraws Ukoniq Approval...
06 May RxAdvocate April, 2022 — Newsletter
Cervical Cancer Immunotherapy House Passes Bill Capping Insulin Prices FDA Approvals RxConnection Organizational Announcements...
25 Mar RxAdvocate March, 2022 — Newsletter
- Purdue Pharma Comes to Opioid Settlement - USPSTF Lowers Bowel Prep Age Recommendation - Psychedelic Therapy - Additional COVID-19 Home Tests - RxConnection Organizational Announcements...
21 Feb RxAdvocate February, 2022 — Newsletter
- COVID-19 Update - PrEP Treatment Guidelines - Hemophilia A - Roctavian Trial Results - Generic Revlimid Capsules Receive FDA Approval - RxConnection Organizational Announcements...
31 Jan RxAdvocate January, 2022 — Newsletter
- COVID-19 At-Home Test Coverage
- COVID-19 Oral Antiviral Medication
22 Dec RxAdvocate December, 2021 — Newsletter
- Biosimilar for Enbrel Blocked Until 2029
- COVID-19 Oral Antiviral Medication Coming Soon
- National Influenza Vaccination Week
09 Nov RxAdvocate November, 2021 — Newsletter
- Pfizer's COVID-19 Vaccine for Kids Aged 5-11
- Eye Drops for Presbyopia
- First Interchangeable Biosimilar Insulin